Streptococcus pyogenes Rosenbach (ATCC® 51500)

Strain Designations: M-3 [DLS 88002, Weller]  /  Type Strain: no  /  Biosafety Level: 2

Permits and Restrictions

View Permits

Strain Designations M-3 [DLS 88002, Weller]
Application
Produces streptococcal superantigen SSA
Characterization of ssa gene
Emerging infectious disease research
Isolation
Blood - human
Boise Idaho, United States
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Lancefield's group A
Product Format freeze-dried
Storage Conditions 2°C to 8°C
Preceptrol® no
Type Strain no
Antigenic Properties Lancefield's group A
Comments
Isolation, patient 1
Name of Depositor DL Stevens
Isolation
Blood - human
Boise Idaho, United States
References

Stevens DL, et al. Severe group A streptococcal infections associated with a toxic shock- like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321: 1-7, 1989. PubMed: 2659990

Mollick JA, et al. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J. Clin. Invest. 92: 710-719, 1993. PubMed: 8349810

Reda KB, et al. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect. Immun. 62: 1867-1874, 1994. PubMed: 8168951

blood of 66-year-old male with streptococcal toxic shock syndrome, Boise

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

Basic Documentation